Vimarsana
Biggest News Aggregation in the World

Page 2 - Diagnostic Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostic Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostic Development Today - Breaking & Trending Today

Global Advances in Gene Editing Technologies in Healthcare Market Report 2023: CRISPR, ZFNs, and TALENs have Revolutionized the Gene Editing Field - Vimarsana News

Global Advances in Gene Editing Technologies in Healthcare Market Report 2023: CRISPR, ZFNs, and TALENs have Revolutionized the Gene Editing Field

/PRNewswire/ -- The "Advances in Gene Editing Technologies in Healthcare" report has been added to ResearchAndMarkets.com's offering. CRISPR, ZFNs, and TALENs...

Xtalks Announces its Life Science Webinar Calendar for November 2022 - Vimarsana News

Xtalks Announces its Life Science Webinar Calendar for November 2022

Toronto, ON (PRWEB) November 01, 2022 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical

Source: prweb.com
WHO and MPP announce agreement with NIH for COVID-19 health technologies - Vimarsana News

WHO and MPP announce agreement with NIH for COVID-19 health technologies

WHO and MPP announce agreement with NIH for COVID-19 health technologies12 May 2022 Geneva – WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalised a licensing agreement with the United States National Institutes of Health (NIH) for the development of sever...

Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine - Vimarsana News

Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine

Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine - read this article along with other careers information, tips and advice on BioSpace

NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program Among Five Pres - Vimarsana News

NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program Among Five Pres

Poster presentation by Pr. Christophe Le Tourneau featuring first OS and PFS data from phase I expansion study of NBTXR3 as a single agent activated by radiotherapy in tough-to-treat HNSCC populationOral presentation by Dr. Tanguy Y. Seiwert with comprehensive review of local and systemic potential effects of NBTXR3...